Maria Atta

483 total citations
22 papers, 249 citations indexed

About

Maria Atta is a scholar working on Immunology, Hematology and Oncology. According to data from OpenAlex, Maria Atta has authored 22 papers receiving a total of 249 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 7 papers in Hematology and 5 papers in Oncology. Recurrent topics in Maria Atta's work include Hepatitis C virus research (5 papers), Systemic Lupus Erythematosus Research (5 papers) and Multiple Myeloma Research and Treatments (4 papers). Maria Atta is often cited by papers focused on Hepatitis C virus research (5 papers), Systemic Lupus Erythematosus Research (5 papers) and Multiple Myeloma Research and Treatments (4 papers). Maria Atta collaborates with scholars based in Brazil, United Kingdom and Greece. Maria Atta's co-authors include Ajax Mercês Atta, Edgar M. Carvalho, Mittermayer Barreto Santiago, Selma M. B. Jerônimo, Roque Pacheco de Almeida, Mittermayer B. Santiago, Rodrigo Cardoso de Oliveira, Raymundo Paraná, Ricardo David Couto and Roque Aras and has published in prestigious journals such as Nature Communications, Blood and British Journal of Haematology.

In The Last Decade

Maria Atta

20 papers receiving 242 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maria Atta Brazil 10 97 81 58 52 50 22 249
Alexandre Aubourg France 7 47 0.5× 119 1.5× 125 2.2× 29 0.6× 23 0.5× 13 299
H. Gheitasi Spain 7 84 0.9× 59 0.7× 28 0.5× 16 0.3× 19 0.4× 12 312
Barbara C. Böckle Austria 10 76 0.8× 95 1.2× 30 0.5× 48 0.9× 14 0.3× 16 266
Catherine Ruiz France 6 58 0.6× 190 2.3× 88 1.5× 36 0.7× 32 0.6× 10 458
Elisa Marocchi Italy 7 204 2.1× 143 1.8× 36 0.6× 38 0.7× 19 0.4× 8 337
Koen M. J. Janssen Netherlands 8 194 2.0× 68 0.8× 21 0.4× 56 1.1× 29 0.6× 11 357
Kuei‐Ying Su Taiwan 10 110 1.1× 157 1.9× 30 0.5× 41 0.8× 12 0.2× 27 312
Alexandra Song United States 7 349 3.6× 82 1.0× 101 1.7× 40 0.8× 39 0.8× 31 919
Vincent Gies France 10 102 1.1× 168 2.1× 26 0.4× 51 1.0× 20 0.4× 18 319
Yiduo Sun China 10 86 0.9× 106 1.3× 71 1.2× 111 2.1× 9 0.2× 21 315

Countries citing papers authored by Maria Atta

Since Specialization
Citations

This map shows the geographic impact of Maria Atta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maria Atta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maria Atta more than expected).

Fields of papers citing papers by Maria Atta

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maria Atta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maria Atta. The network helps show where Maria Atta may publish in the future.

Co-authorship network of co-authors of Maria Atta

This figure shows the co-authorship network connecting the top 25 collaborators of Maria Atta. A scholar is included among the top collaborators of Maria Atta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maria Atta. Maria Atta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Khwaja, Jahanzaib, Maria Atta, Ceri Bygrave, et al.. (2024). Real‐world efficacy of single‐agent belantamab mafodotin in relapsed systemic AL amyloidosis. British Journal of Haematology. 204(5). 1811–1815. 5 indexed citations
2.
Blakey, Sarah, Linda Moran, Maria Atta, et al.. (2023). Non-crystalline light chain proximal tubulopathy, a morphologically protean entity. Nephrology Dialysis Transplantation. 38(11). 2576–2588. 4 indexed citations
3.
Ren, Hongwei, Irene Sarkar, Marco Bua, et al.. (2023). Optimal, Off-the-Shelf, CAR-iNKT Cell Platform-Based Immunotherapy for Multiple Myeloma. Blood. 142(Supplement 1). 3459–3459.
4.
Bua, Marco, et al.. (2023). Development of Novel Invariant TCR-Anchored Bispecific Engagers to Enhance Anti-Cancer Activity of iNKT Cells. Blood. 142(Supplement 1). 4828–4828. 2 indexed citations
5.
Chaidos, Aristeidis, Philippa C. May, Xiaolin Xiao, et al.. (2021). Chromatin-based, in cis and in trans regulatory rewiring underpins distinct oncogenic transcriptomes in multiple myeloma. Nature Communications. 12(1). 5450–5450. 26 indexed citations
6.
Atta, Maria, et al.. (2021). IgE antibodies to hepatitis C virus core and nonstructural antigens in chronic hepatitis C patients before and after antiviral treatment. International Immunopharmacology. 93. 107405–107405. 1 indexed citations
7.
Cooper, Nichola, Melanie A. Morrison, Thomas W. Young, et al.. (2020). Identification of occult cerebral microbleeds in adults with immune thrombocytopenia. Blood. 136(25). 2875–2880. 6 indexed citations
8.
Atta, Ajax Mercês, et al.. (2018). Clinical and laboratory aspects of dyslipidemia in Brazilian women with systemic lupus erythematosus. Clinical Rheumatology. 37(6). 1539–1546. 15 indexed citations
9.
Atta, Maria, Eimear Brannigan, & Barbara J. Bain. (2016). Cold autoimmune hemolytic anemia secondary to atypical pneumonia. American Journal of Hematology. 92(1). 109–109. 4 indexed citations
10.
Tsantes, Argirios Ε., Elias Kyriakou, Stefanos Bonovas, et al.. (2015). Impact of dabigatran on platelet function and fibrinolysis. Journal of the Neurological Sciences. 357(1-2). 204–208. 11 indexed citations
11.
Carvalho, Lucas P., et al.. (2015). Peripheral lymphocyte subsets in chronic hepatitis C: Effects of 12 weeks of antiviral treatment with interferon-alpha plus ribavirin. Microbial Pathogenesis. 91. 155–160. 3 indexed citations
12.
Paraná, Raymundo, et al.. (2014). Serum levels of immunoglobulin free light chains in patients with chronic hepatitis C presenting cryoglobulinemia. The Brazilian Journal of Infectious Diseases. 18(6). 638–642. 10 indexed citations
13.
Atta, Ajax Mercês, et al.. (2014). Higher level of IL-6 in Jaccoud’s arthropathy secondary to systemic lupus erythematosus: a perspective for its treatment?. Rheumatology International. 35(1). 167–170. 10 indexed citations
14.
Aras, Roque, et al.. (2013). Serum levels of cytokines and chemokines associated with cardiovascular disease in Brazilian patients treated with statins for dyslipidemia. International Immunopharmacology. 18(1). 66–70. 15 indexed citations
15.
Atta, Maria, et al.. (2012). Inflammation biomarkers in chronic hepatitis C: association with liver histopathology, HCV genotype and cryoglobulinemia. Inflammation Research. 61(10). 1101–1106. 12 indexed citations
16.
Atta, Ajax Mercês, et al.. (2010). Autoimmune Response of IgE Antibodies to Cellular Self-Antigens in Systemic Lupus Erythematosus. International Archives of Allergy and Immunology. 152(4). 401–406. 44 indexed citations
17.
18.
Atta, Ajax Mercês, Edgar M. Carvalho, Selma M. B. Jerônimo, & Maria Atta. (2007). Serum markers of rheumatoid arthritis in visceral leishmaniasis: Rheumatoid factor and anti-cyclic citrullinated peptide antibody. Journal of Autoimmunity. 28(1). 55–58. 29 indexed citations
19.
Atta, Maria, et al.. (2006). Autoimmune Aspects of Hepatitis C in Bahia (Brazil). JCR Journal of Clinical Rheumatology. 12(2). S6–S6. 2 indexed citations
20.
Atta, Ajax Mercês, et al.. (1998). Anti-leishmanial IgE antibodies: a marker of active disease in visceral leishmaniasis.. American Journal of Tropical Medicine and Hygiene. 59(3). 426–430. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alexandre Aubourg Breakdown of academic impact, for papers by H. Gheitasi Breakdown of academic impact, for papers by Barbara C. Böckle Breakdown of academic impact, for papers by Catherine Ruiz Breakdown of academic impact, for papers by Elisa Marocchi Breakdown of academic impact, for papers by Koen M. J. Janssen Breakdown of academic impact, for papers by Kuei‐Ying Su Breakdown of academic impact, for papers by Alexandra Song Breakdown of academic impact, for papers by Vincent Gies Breakdown of academic impact, for papers by Yiduo Sun
Rankless by CCL
2026